AA
Ascentage Pharma Group International
AAPG · NASDAQ
$15.06 -2.02% (-$0.31)
1M -9.87%
Market Cap ¥2.34B
P/E Ratio -
Div. Yield -
ROE 171.96%
Piotroski F-Score Weak
2/9Valuation
68 /100
Cheap P/S 4.19x
P/B 1.77x
P/E N/A
Growth
100 /100
Growing Rev. growth 38.61%
Book val. growth 48.02%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 76.41%
FCF margin 215.17%
Net margin 216.47%
Quality
2 /100
Poor ROIC 33.45%
Asset turnover 0.14x
ROE 171.96%
Debt
37 /100
Moderate Debt/Equity 1.49x
Int. coverage -22.42x
Current ratio 1.79x
Stability
26 /100
Unstable Beta 0.66x
Profitable years 0
Rev. volatility 209.49%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o AAPG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Nadchodzące wydarzenia
31 MAR
Earnings
Upcoming earnings report